Dr Ghita Benabdallah is a pharmacist, graduated from the Faculty of Pharmacy of the University of Monastir. Monastir, Tunisia.
She started her career in a private pharmacy in Rabat, Morocco for 5 years before joining the Centre Anti Poison et de Pharmacovigilance du Maroc (CAPM), in 2001.
Since 2001: Working in the pharmacovigilance (PV) department, focusing on all PV activities, on promoting patient safety, preventing medication errors, and risk minimization actions.
Since 2006: Involved in various projects in collaboration with the World Health Organization, the World Alliance for Patient Safety, and the Uppsala Monitoring centre (UMC) in Uppsala, Sweden and the Moroccan pharmacovigilance centre to assess the capacity of pharmacovigilance centers to detect and analyze medication errors and to broaden the scope of national pharmacovigilance centers.
She participated with the Moroccan pharmacovigilance team in the development of a new WHO guideline: Reporting and learning systems for medication errors: The role of pharmacovigilance centers.
Since 2011, as the CAPM has been designated a WHO Collaborating Centre for strengthening pharmacovigilance practices, she is involved in trainings in PV and capacity building of health professionals in French-speaking African countries and countries of the Eastern Mediterranean region.
Since 2020, she is involved in pharmacovigilance trainings and capacity building of health of health professionals to handle the surveillance of covid 19 vaccines.
Dr Ghita Benabdallah is a member of several pharmacovigilance societies and international networks for patient safety, medication errors and vaccines.